Will a GLP-1 Show Up on a Drug Test?
Why semaglutide and tirzepatide are not on standard drug panels, and why phentermine is the one weight-loss medication worth disclosing.
If you take a GLP-1 for weight loss and you have a drug test coming up, whether it is for a new job, a commercial driving role, or a workplace safety program, it is natural to wonder what will show up. The short version is reassuring, and it helps to understand why. Standard drug tests look for a specific short list of drugs of abuse, and a GLP-1 is not on that list.
The short answer
Semaglutide and tirzepatide do not appear on standard workplace or federal drug tests. They are not controlled substances, they are not among the drug classes these panels screen for, and there are no known published reports of them causing a false positive on the usual screens. If a GLP-1 is the only prescription that gives you pause, you can relax. The chemistry of these tests simply does not have a slot for it.
What a standard drug test actually looks for
The most common workplace test is the federal five-panel used under SAMHSA and Department of Transportation rules. It screens for five classes of substances:
Ready to start?
$199 Skeptics' Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trial- Marijuana (THC)
- Cocaine metabolite
- Amphetamines
- Opioids and opiates
- PCP
The first step is an immunoassay screen, which is a fast, antibody-based test. If a sample comes back as a presumptive positive, the lab does not stop there. It runs a confirmatory test using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography with tandem mass spectrometry (LC-MS/MS), which identifies the exact molecule. None of the five screened classes is a GLP-1 medication.
Why a peptide like semaglutide has no analyte
Here is the mechanical reason a GLP-1 does not register. Immunoassay drug screens are built to detect small-molecule drugs of abuse. Semaglutide and tirzepatide are large peptide molecules, closer in size and structure to the body's own hormones than to a street stimulant. The panels have no assay aimed at these peptides, and there is no established mechanism for them to cross-react with the amphetamine, opioid, THC, cocaine, or PCP antibodies. In other words, the test is not detecting a GLP-1 and then excusing it. There is nothing on the panel that even looks for it.
This is a separate question from routine bloodwork, where a GLP-1 can affect certain readings your doctor orders on purpose. If that is what you are curious about, we cover it in GLP-1 and lab tests. A workplace drug screen and a clinical lab panel are looking for entirely different things.
The one weight-loss medication worth flagging: phentermine
If your weight plan includes phentermine, the picture is different, and this is the part worth knowing before test day. Phentermine is a DEA Schedule IV controlled substance, prescribed short-term for weight loss and classified that way because of its amphetamine-like stimulant mechanism. Structurally it is a sympathomimetic amine similar to amphetamine, and that similarity is exactly what can matter on a screen.
Because of that resemblance, phentermine can cross-react with the antibodies an immunoassay uses to detect amphetamines. That can produce a presumptive positive on the amphetamine screen. One peer-reviewed analysis of a specific ELISA kit reported high cross-reactivity with the amphetamine antibody in that particular test and matrix, and notably no cross-reactivity with the methamphetamine antibody. That percentage is specific to one kit and should not be treated as a universal number, but the direction is clear: phentermine can look like amphetamine to a screen, not like methamphetamine. Phentermine is also minimally metabolized, so it can reach concentrations high enough to trip the screen, whereas many other cross-reacting substances are broken down too quickly to do so. Phentermine and semaglutide work very differently, and we compare them directly in semaglutide vs phentermine.
A presumptive positive is not a failed test
This is the point that keeps people from panicking unnecessarily. A presumptive positive on the amphetamine screen is not the final result. It is a flag that triggers confirmatory testing. The GC-MS or LC-MS/MS step distinguishes phentermine from illicit amphetamine or methamphetamine, because it identifies the precise molecule rather than just a family resemblance. A screen positive caused by a legitimate, prescribed medication is a resolvable step in the process, not an automatic mark against you.
Tell the Medical Review Officer about everything you take
Most regulated drug tests involve a Medical Review Officer, a licensed physician who reviews results before they are reported. Disclosing every prescription and over-the-counter product you take, ideally with documentation, lets the MRO verify legitimate therapeutic use. When a phentermine prescription is valid and documented, the MRO can report a confirmed result as consistent with authorized medication use rather than an illicit finding. The habit that protects you is honesty, not timing or concealment. Keeping your prescriptions documented and easy to explain helps in other settings too, such as when you are traveling with a GLP-1.
Do not stop, pause, hide, or reschedule any medication around a drug test on your own. Any change to a prescription is a conversation for the person who prescribes it, and the honest, documented route is the one that holds up.
A note on scope
Everything above describes standard workplace and DOT immunoassay panels. Specialized testing programs, such as competitive sports anti-doping, follow their own rules and prohibited lists and are a separate topic outside what we are covering here. If you are subject to one of those programs, check its specific guidance.
One more clarification for anyone using a compounded product: compounded semaglutide and tirzepatide are the same class of peptide medication as the branded versions, so they behave the same way on these panels, meaning there is still no analyte for a standard screen to detect. Compounded formulations are not FDA-approved and not brand-identical, and results vary by individual, but none of that changes the drug-panel chemistry.
The practical takeaway
For a standard drug test, a GLP-1 like semaglutide or tirzepatide is a non-issue: it is not a controlled substance, it is not screened, and it has no known false-positive mechanism. If phentermine is part of your plan, it can trigger a presumptive amphetamine screen that confirmatory testing and MRO review sort out when you have a valid prescription on file. Either way, the same simple move covers you: tell the testing lab's Medical Review Officer about every medication and supplement you take, and let the documented, honest process do its job. This is general education, not legal, employment, or personalized medical advice, and if a specific test has you worried, bring the details to your prescriber.
Ozempic and Wegovy are trademarks of Novo Nordisk. Mounjaro and Zepbound are trademarks of Eli Lilly. New Hope Weight Loss and Wellness is not affiliated with either company.
Frequently asked questions
Does semaglutide or tirzepatide show up on a standard drug test?
No. Semaglutide and tirzepatide are not controlled substances and are not among the classes screened on a standard workplace or DOT five-panel test, which looks for marijuana, cocaine, amphetamines, opioids, and PCP. They are large peptide molecules that the immunoassay has no assay for, and there are no known reports of them causing a false positive.
Can a GLP-1 cause a false positive for amphetamines or another drug?
There is no established mechanism for semaglutide or tirzepatide to cross-react with the amphetamine, opioid, THC, cocaine, or PCP antibodies used in immunoassay screens. The concern people are often thinking of is phentermine, a different weight-loss medication, not a GLP-1.
Will phentermine make me fail a drug test?
Not automatically. Phentermine is structurally similar to amphetamine and can trigger a presumptive positive on the amphetamine screen. That flag leads to confirmatory testing by GC-MS or LC-MS/MS, which distinguishes phentermine from illicit drugs. With a valid, documented prescription reviewed by the Medical Review Officer, it can be reported as authorized medication use rather than an illicit finding.
Should I stop my medication before a drug test?
No. Do not stop, pause, hide, or reschedule any prescription on your own before a test. Any change to a medication is a decision for the person who prescribes it. The route that protects you is honest disclosure, not concealment or timing.
What should I tell the Medical Review Officer?
Disclose every prescription and over-the-counter product you take, ideally with documentation such as a pharmacy label or a note from your prescriber. This lets the Medical Review Officer verify legitimate therapeutic use and correctly interpret any presumptive result, including one caused by phentermine.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.